Read the full Report (pdf)
European College of Neuropsychopharmacology
2–5 October 2021
Featured articles
EditorProf. Martien Kas, University of Groningen, the Netherlands
ConferenceECNP 2021
26 November 2021 12:39
Presented ByDr Rachel Giles, Medicom
TrialWATERFALL, RECONNECT ConferenceECNP 2021
20 October 2021 00:22
Anxiety and Stress
Presented ByDr Mark Schmidt, Janssen, Belgium
ConferenceECNP 2021
TypePeer-reviewed article
26 November 2021 10:51
ExpertNottingham University Hospital, UK
ConferenceECNP2021
TypePeer-reviewed article
26 November 2021 10:47
Autism
Presented ByDr Hanna Hörnberg; Dr Emily Jones; Dr Clara Moreau; Prof. Louise Gallagher
TrialAIMS-2-TRIALS ConferenceECNP 2021
TypePeer-reviewed article
26 November 2021 10:55
Behavioural Disorders
Presented ByDr Graeme Fairchild, University of Bath, UK
ConferenceECNP 2021
TypePeer-reviewed article
26 November 2021 11:10
Presented ByDr Tõnis Tokko, University of Tartu, Estonia
ConferenceECNP 2021
TypePeer-reviewed article
26 November 2021 11:08
Presented ByDr Tom Freeman , University of Bath, UK
ConferenceECNP 2021
TypePeer-reviewed article
26 November 2021 11:05
Presented ByDr Isabell Brikell , Karolinska Institutet, Sweden
ConferenceECNP 2021
TypePeer-reviewed article
26 November 2021 11:02
Presented ByDr David Slattery, Goethe University, Germany ; Dr Joana Vieira, Karolinska Institute, Sweden
ConferenceECNP 2021
TypePeer-reviewed article
26 November 2021 10:59
COVID-19
Presented ByMs Agnese Merlo & Ms Pauline A. Hendriksen, Utrecht Institute for Pharmaceutical Sciences
ConferenceECNP 2021
TypePeer-reviewed article
26 November 2021 11:19
Presented ByDr Mario Mazza , San Raffaele University, Italy
ConferenceECNP 2021
TypePeer-reviewed article
26 November 2021 11:17
Presented ByDr Amir Krivoy, Tel-Aviv University, Israel
ConferenceECNP 2021
TypePeer-reviewed article
26 November 2021 11:14
Mood Disorders
Presented ByMs Julia Binnewies , University of Groningen, the Netherlands
ConferenceECNP 2021
TypePeer-reviewed article
26 November 2021 11:54
Presented ByDr Johan Sandin, AlzeCure Pharma, Sweden
ConferenceECNP 2021
TypePeer-reviewed article
26 November 2021 11:52
Presented ByDr Anita Clayton , University of Virginia, VA, USA
TrialPhase 3, WATERFALL ConferenceECNP 2021
TypePeer-reviewed article
26 November 2021 11:48
Presented ByDr Michael Christensen , H. Lundbeck A/S, Denmark
TrialPhase 4, RECONNECT ConferenceECNP 2021
TypePeer-reviewed article
26 November 2021 11:45
Presented ByMr Joachim Morrens , Janssen EMEA, Belgium
TrialPhase 3, SUSTAIN-2; EOTC ConferenceECNP 2021
TypePeer-reviewed article
26 November 2021 11:42
Presented ByDr Gerard Anmella, University of Barcelona, Spain
TypePeer-reviewed article
26 November 2021 11:39
Presented ByProf. Manon Hillegers , Erasmus MC Sophia, the Netherlands
ConferenceECNP 2021
TypePeer-reviewed article
26 November 2021 11:36
Personality Disorders
Presented ByMs Sonia Gutiérrez , Oryzon, Spain
TrialPhase 2, PORTICO ConferenceECNP 2021
TypePeer-reviewed article
26 November 2021 11:41
Presented ByMs Ilse Graat, Amsterdam University Medical Center, the Netherlands
ConferenceECNP 2021
TypePeer-reviewed article
26 November 2021 11:38
Psychotic Disorders
Presented ByProf. Louise Gallagher, University of Dublin, Ireland
ConferenceECNP 2021
TypePeer-reviewed article
26 November 2021 11:18
Presented ByProf. Michael Davidson , Nicosia Medical School, Cyprus
ConferenceECNP 2021
TypePeer-reviewed article
26 November 2021 11:15
Other
Presented ByProf. Jes Olesen, University of Copenhagen, Denmark
ConferenceECNP 2021
TypePeer-reviewed article
26 November 2021 11:02
Presented ByMs Angharad de Cates , University of Oxford, UK
ConferenceECNP 2021
TypePeer-reviewed article
26 November 2021 11:01
